308
Views
52
CrossRef citations to date
0
Altmetric
Original Research

Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms

, , , , , & show all
Pages 2697-2708 | Published online: 03 May 2018

References

  • DelaloyeJCalandraTInvasive candidiasis as a cause of sepsis in the critically ill patientVirulence20145116116924157707
  • HarriottMMNoverrMCImportance of Candida-bacterial polymicrobial biofilms in diseaseTrends Microbiol2011191155756321855346
  • GahlotRNigamCKumarVYadavGAnupurbaSCatheter-related bloodstream infectionsInt J Crit Illn Inj Sci20144216216725024944
  • MathéLVan DijckPRecent insights into Candida albicans biofilm resistance mechanismsCurr Genet201359425126423974350
  • ChatterjeeSMaitiPDeyRKunduADeyRBiofilms on indwelling urologic devices: microbes and antimicrobial management prospectAnn Med Health Sci Res20144110010424669340
  • MayerFLWilsonDHubeBCandida albicans pathogenicity mechanismsVirulence20134211912823302789
  • TaffHTMitchellKFEdwardJAAndesDRMechanisms of Candida biofilm drug resistanceFuture Microbiol20138101325133724059922
  • KuhnDMGeorgeTChandraJMukherjeePKGhannoumMAAntifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandinsAntimicrob Agents Chemother20024661773178012019089
  • LiuSYueLGuWLiXZhangLSunSSynergistic effect of fluconazole and calcium channel blockers against resistant Candida albicansPLoS One2016113e015085926986478
  • LeekhaSTerrellCLEdsonRSGeneral principles of antimicrobial therapyMayo Clin Proc201186215616721282489
  • MaLKohliMSmithANanoparticles for combination drug therapyACS Nano20137119518952524274814
  • FoucquierJGuedjMAnalysis of drug combinations: current methodological landscapePharmacol Res Perspect201533e0014926171228
  • ChouT-CDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
  • ChouT-CTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
  • ChangTTChouTCRational approach to the clinical protocol design for drug combinations: a reviewActa Paediatr Taiwan200041629430211198934
  • BijnsdorpIVGiovannettiEPetersGJAnalysis of drug interactionsMethods Mol Biol201173142143421516426
  • YadavBWennerbergKAittokallioTTangJSearching for drug synergy in complex dose-response landscapes using an interaction potency modelComput Struct Biotechnol J20151350451326949479
  • DiasMFBernardes-FilhoFQuaresma-SantosMVAmorimAGSchechtmanRCAzulayDRTreatment of superficial mycoses: review. Part IIAn Bras Dermatol201388693794424474103
  • GuisbiersGLaraHHMendoza-CruzRInhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquidsNanomedicine20171331095110327793789
  • TinggiUSelenium: its role as antioxidant in human healthEnviron Health Prev Med200813210210819568888
  • KieliszekMBłażejakSKurekEBinding and conversion of selenium in Candida utilis ATCC 9950 yeasts in bioreactor cultureMolecules2017223352
  • RaoLMaYZhuangMLuoTWangYHongAChitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitusInt J Nanomedicine201494819482825378923
  • KieliszekMBłażejakSGientkaIBzducha-WróbelAAccumulation and metabolism of selenium by yeast cellsAppl Microbiol Biotechnol201599135373538226003453
  • KieliszekMBłażejakSPłaczekMSpectrophotometric evaluation of selenium binding by Saccharomyces cerevisiae ATCC MYA-2200 and Candida utilis ATCC 9950 yeastJ Trace Elem Med Biol201635909627049131
  • KieliszekMBłażejakSBzducha-WróbelAKurczAEffects of selenium on morphological changes in Candida utilis ATCC 9950 yeast cellsBiol Trace Elem Res2016169238739326166197
  • HerreroEWellingerREYeast as a model system to study metabolic impact of selenium compoundsMicrob Cell20152513914928357286
  • LetavayováLVlasákováDSpallholzJEBrozmanováJChovanecMToxicity and mutagenicity of selenium compounds in Saccharomyces cerevisiaeMutat Res2008638111017900630
  • ZhaiXZhangCZhaoGStollSRenFLengXAntioxidant capacities of the selenium nanoparticles stabilized by chitosanJ Nanobiotechnology2017151428056992
  • ZhangSLuoYZengHEncapsulation of selenium in chitosan nanoparticles improves selenium availability and protects cells from selenium-induced DNA damage responseJ Nutr Biochem201122121137114221292467
  • PeñaASánchezNSCalahorraMEffects of chitosan on Candida albicans: conditions for its antifungal activityBiomed Res Int2013201352754923844364
  • KvasničkováEPaulíčekVPaldrychováMJeždíkRMaťátkováOMasákJAspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipidWorld J Microbiol Biotechnol2016321118727660214
  • PuYLiuAZhengYYeBIn vitro damage of Candida albicans biofilms by chitosanExp Ther Med20148392993425120626
  • CheungRCFNgTBWongJHChanWYChitosan: an update on potential biomedical and pharmaceutical applicationsMar Drugs20151385156518626287217
  • DaiTTanakaMHuangY-YHamblinMRChitosan preparations for wounds and burns: antimicrobial and wound-healing effectsExpert Rev Anti Infect Ther20119785787921810057
  • ZhuXRadovic-MorenoAFWuJLangerRShiJNanomedicine in the management of microbial infection – overview and perspectivesNano Today20149447849825267927
  • PierceCGSrinivasanAUppuluriPRamasubramanianAKLópez-RibotJLAntifungal therapy with an emphasis on biofilmsCurr Opin Pharmacol201313572673024011516
  • SinghRSmithaMSSinghSPThe role of nanotechnology in combating multi-drug resistant bacteriaJ Nanosci Nanotechnol20141474745475624757944
  • MonteiroDRGorupLFSilvaSSilver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrataBiofouling201127771171921756192
  • SilvaSPiresPMonteiroDRThe effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylicMed Mycol201351217818422803822
  • ShakibaieMSalari MohazabNAyatollahi MousaviSAAntifungal activity of selenium nanoparticles synthesized by Bacillus species Msh-1 against Aspergillus fumigatus and Candida albicansJundishapur J Microbiol201589e2638126495111
  • KheradmandERafiiFYazdiMHSepahiAAShahverdiAROveisiMRThe antimicrobial effects of selenium nanoparticle-enriched probiotics and their fermented broth against Candida albicansDaru2014224824906455
  • CremoniniEZonaroEDoniniMBiogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblastsMicrob Biotechnol20169675877127319803
  • PierceCGUppuluriPTristanARA simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testingNat Protoc2008391494150018772877
  • PierceCGUppuluriPTummalaSLopez-RibotJLA 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilmsJ Vis Exp Epub20101021
  • PierceCGLopez-RibotJLCandidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugsExpert Opin Drug Discov2013891117112623738751
  • BijnsdorpIVGiovannettiEPetersGJAnalysis of drug interactionsMethods Mol Biol201173142143421516426
  • GillumAMTsayEYKirschDRIsolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutationsMol Gen Genet198419821791826394964
  • SinghAYadavVPrasadRComparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistancePLoS One201276e3981222761908
  • LohbergerACosteATSanglardDDistinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulenceEukaryot Cell201413112714224243794
  • PierceCGChaturvediAKLazzellALA novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistanceNPJ Biofilms Microbiomes2015111501226691764
  • VilaTVMChaturvediAKRozentalSLopez-RibotJLIn vitro activity of miltefosine against Candida albicans under planktonic and biofilm growth conditions and in vivo efficacy in a murine model of oral candidiasisAntimicrob Agents Chemother201559127611762026416861
  • MatsumotoATamuraAHondaTTransfer of the species dissolved in a liquid into laser ablation plasma: an approach using emission spectroscopyJ Phys Chem2015119472650626511
  • GuisbiersGWangQKhachatryanEAnti-bacterial selenium nanoparticles produced by UV/VIS/NIR pulsed nanosecond laser ablation in liquidsLaser Phys Lett201512116003
  • YuBZhangYZhengWFanCChenTPositive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticlesInorg Chem201251168956896322873404
  • MartinezLRMihuMRTarMDemonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter modelJ Infect Dis201020191436144020331379
  • SilesSASrinivasanAPierceCGLopez-RibotJLRamasubramanianAKHigh-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitorsAntimicrob Agents Chemother20135783681368723689719
  • YuDKahenECubittCLIdentification of synergistic, clinically achievable, combination therapies for osteosarcomaSci Rep201551699126601688
  • LaraHHRomero-UrbinaDGPierceCLopez-RibotJLArellano-JiménezMJJose-YacamanMEffect of silver nanoparticles on Candida albicans biofilms: an ultrastructural studyJ Nanobiotechnology2015139126666378
  • Di VeroliGYFornariCGoldlustIAn automated fitting procedure and software for dose-response curves with multiphasic featuresSci Rep201551470126424192
  • FischerERHansenBTNairVHoytFHDorwardDWScanning electron microscopyCurr Protoc Microbiol2012 Chapter 2:Unit2B.2
  • KuwajimaMMendenhallJMLindseyLFHarrisKMAutomated transmission-mode scanning electron microscopy (tSEM) for large volume analysis at nanoscale resolutionPLoS One201383e5957323555711